Severe atopic dermatitis in a 21-month-old boy successfully treated with dupilumab.

Daniel Mazzoni Yolanka LoboDavid LevittLaura Wheller

Published in: Pediatric dermatology (2022)

While dupilumab has emerged as a novel targeted systemic treatment for severe AD, efficacy and safety-based data in young children are limited. We discuss the case of a 21-month-old child with severe recalcitrant atopic dermatitis successfully treated with dupilumab.

Keyphrases

atopic dermatitis
early onset
drug induced
mental health
cancer therapy
big data
combination therapy
replacement therapy